FourThought Financial, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.

Quarter-by-quarter ownership
FourThought Financial, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$21,000
+10.5%
683
+17.2%
0.00%
+50.0%
Q1 2022$19,000
+26.7%
5830.0%0.00%0.0%
Q4 2021$15,000
-74.1%
5830.0%0.00%
-75.0%
Q3 2021$58,000
+11.5%
583
+58.0%
0.01%
+14.3%
Q2 2021$52,000
+44.4%
3690.0%0.01%
+40.0%
Q1 2021$36,000
-30.8%
369
-13.4%
0.01%
-37.5%
Q4 2020$52,0004260.01%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders